Core Laboratories Company Profile (NYSE:CLB)

About Core Laboratories (NYSE:CLB)

Core Laboratories logoCore Laboratories N.V. provides reservoir description, production enhancement and reservoir management services to the oil and gas industry. The Company operates through three segments: Reservoir Description, Production Enhancement and Reservoir Management. The Reservoir Description segment encompasses the characterization of petroleum reservoir rock, fluid and gas samples. It provides analytical and field services to characterize properties of crude oil and petroleum products to the oil and gas industry. The Production Enhancement segment includes products and services relating to reservoir well completions, perforations, stimulations and production. It provides integrated diagnostic services to evaluate the effectiveness of well completions. The Reservoir Management segment combines and integrates information from reservoir description and production enhancement services to increase production and recovery of oil and gas from its clients' reservoirs.

Industry, Sector and Symbol:
  • Sector: Oils/Energy
  • Industry: Oil & Gas Equipment & Services
  • Sub-Industry: N/A
  • Symbol: NYSE:CLB
  • CUSIP: N/A
  • Web:
  • Market Cap: $4.54 billion
  • Outstanding Shares: 44,182,000
Average Prices:
  • 50 Day Moving Avg: $110.54
  • 200 Day Moving Avg: $113.85
  • 52 Week Range: $96.30 - $133.38
  • Trailing P/E Ratio: 68.02
  • Foreward P/E Ratio: 31.90
  • P/E Growth: 1.14
Sales & Book Value:
  • Annual Revenue: $598.9 million
  • Price / Sales: 7.58
  • Book Value: $3.38 per share
  • Price / Book: 30.39
  • Annual Dividend: $2.20
  • Dividend Yield: 2.2%
  • EBIDTA: $114.34 million
  • Net Margins: 10.74%
  • Return on Equity: 65.65%
  • Return on Assets: 11.51%
  • Debt-to-Equity Ratio: 1.27%
  • Current Ratio: 1.98%
  • Quick Ratio: 1.58%
  • Average Volume: 481,636 shs.
  • Beta: 1.55
  • Short Ratio: 16.27

Frequently Asked Questions for Core Laboratories (NYSE:CLB)

What is Core Laboratories' stock symbol?

Core Laboratories trades on the New York Stock Exchange (NYSE) under the ticker symbol "CLB."

How often does Core Laboratories pay dividends? What is the dividend yield for Core Laboratories?

Core Laboratories announced a quarterly dividend on Wednesday, April 19th. Stockholders of record on Friday, April 28th will be given a dividend of $0.55 per share on Tuesday, May 23rd. This represents a $2.20 dividend on an annualized basis and a dividend yield of 2.14%. The ex-dividend date is Thursday, April 27th. View Core Laboratories' Dividend History.

How were Core Laboratories' earnings last quarter?

Core Laboratories (NYSE:CLB) issued its quarterly earnings results on Wednesday, April, 19th. The company reported $0.42 EPS for the quarter, beating analysts' consensus estimates of $0.39 by $0.03. The firm had revenue of $157.81 million for the quarter, compared to the consensus estimate of $150.44 million. Core Laboratories had a net margin of 10.74% and a return on equity of 65.65%. The business's revenue was up 2.7% compared to the same quarter last year. During the same quarter last year, the firm earned $0.37 EPS. View Core Laboratories' Earnings History.

When will Core Laboratories make its next earnings announcement?

Core Laboratories is scheduled to release their next quarterly earnings announcement on Tuesday, July, 18th 2017. View Earnings Estimates for Core Laboratories.

What guidance has Core Laboratories issued on next quarter's earnings?

Core Laboratories issued an update on its second quarter earnings guidance on Wednesday, April, 19th. The company provided earnings per share (EPS) guidance of $0.48-0.52 for the period, compared to the Thomson Reuters consensus estimate of $0.48. The company issued revenue guidance of $165-170 million, compared to the consensus revenue estimate of $160.18 million.

Where is Core Laboratories' stock going? Where will Core Laboratories' stock price be in 2017?

12 analysts have issued 12-month price targets for Core Laboratories' shares. Their predictions range from $91.00 to $180.00. On average, they anticipate Core Laboratories' stock price to reach $125.56 in the next year. View Analyst Ratings for Core Laboratories.

Who are some of Core Laboratories' key competitors?

Who owns Core Laboratories stock?

Core Laboratories' stock is owned by a variety of of retail and institutional investors. Top institutional investors include WCM Investment Management CA (9.35%), Vanguard Group Inc. (8.18%), Earnest Partners LLC (4.17%), Sustainable Growth Advisers LP (3.88%), Kayne Anderson Rudnick Investment Management LLC (3.80%) and BlackRock Inc. (3.62%). Company insiders that own Core Laboratories stock include Jan Willem Sodderland, Martha Z Carnes and Michael Straughen. View Institutional Ownership Trends for Core Laboratories.

Who sold Core Laboratories stock? Who is selling Core Laboratories stock?

Core Laboratories' stock was sold by a variety of institutional investors in the last quarter, including Bank of America Corp DE, Granahan Investment Management Inc. MA, WASHINGTON TRUST Co, Wedgewood Partners Inc., KBC Group NV, Russell Investments Group Ltd., Janus Capital Management LLC and Asset Management One Co. Ltd.. View Insider Buying and Selling for Core Laboratories.

Who bought Core Laboratories stock? Who is buying Core Laboratories stock?

Core Laboratories' stock was acquired by a variety of institutional investors in the last quarter, including BlackRock Inc., RidgeWorth Capital Management LLC, JPMorgan Chase & Co., WCM Investment Management CA, Renaissance Technologies LLC, Sustainable Growth Advisers LP, Bank of Montreal Can and Vanguard Group Inc.. Company insiders that have bought Core Laboratories stock in the last two years include Jan Willem Sodderland, Martha Z Carnes and Michael Straughen. View Insider Buying and Selling for Core Laboratories.

How do I buy Core Laboratories stock?

Shares of Core Laboratories can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Core Laboratories stock cost?

One share of Core Laboratories stock can currently be purchased for approximately $102.71.

Analyst Ratings

Consensus Ratings for Core Laboratories (NYSE:CLB) (?)
Ratings Breakdown: 2 Sell Ratings, 7 Hold Ratings, 3 Buy Ratings
Consensus Rating:Hold (Score: 2.08)
Consensus Price Target: $125.56 (22.24% upside)

Analysts' Ratings History for Core Laboratories (NYSE:CLB)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
4/22/2017ScotiabankSet Price TargetHold$136.00LowView Rating Details
4/21/2017ABN AmroUpgradeHoldLowView Rating Details
4/21/2017Loop CapitalUpgradeHold -> Buy$125.00 -> $130.00LowView Rating Details
3/23/2017Tudor PickeringInitiated CoverageHoldLowView Rating Details
3/11/2017Citigroup IncReiterated RatingNeutral$119.00 -> $117.00N/AView Rating Details
12/7/2016StephensDowngradeEqual Weight -> Sell$91.00N/AView Rating Details
12/6/2016GuggenheimDowngradeBuy -> NeutralN/AView Rating Details
10/22/2016Cowen and CompanyReiterated RatingMarket Perform$105.00N/AView Rating Details
10/5/2016DA DavidsonInitiated CoverageBuy$136.00N/AView Rating Details
9/1/2016Credit Suisse Group AGInitiated CoverageNeutral$115.00N/AView Rating Details
7/12/2016JPMorgan Chase & Co.DowngradeNeutral -> UnderweightN/AView Rating Details
6/13/2016KLR GroupReiterated RatingBuy$166.00 -> $180.00N/AView Rating Details
4/23/2016Royal Bank of CanadaReiterated RatingBuyN/AView Rating Details
4/23/2016SimmonsReiterated RatingHold$105.00 -> $115.00N/AView Rating Details
4/19/2016Morgan StanleyBoost Price TargetOverweight$120.00 -> $140.00N/AView Rating Details
3/28/2016Howard WeilBoost Price Target$112.00N/AView Rating Details
2/10/2016ING GroupLower Price TargetHold$125.00 -> $112.00N/AView Rating Details
2/2/2016William BlairReiterated RatingOutperformN/AView Rating Details
1/29/2016SunTrust Banks, Inc.Lower Price TargetBuy$123.00 -> $109.00N/AView Rating Details
1/29/2016Iberia CapitalLower Price TargetOutperform$140.00 -> $115.00N/AView Rating Details
1/26/2016HSBC Holdings plcDowngradeHold -> ReduceN/AView Rating Details
1/11/2016Oppenheimer Holdings Inc.Initiated CoverageMarket PerformN/AView Rating Details
9/30/2015Sterne Agee CRTLower Price TargetNeutral$113.00 -> $108.00N/AView Rating Details
(Data available from 5/27/2015 forward)


Earnings History for Core Laboratories (NYSE:CLB)
Earnings by Quarter for Core Laboratories (NYSE:CLB)
Earnings History by Quarter for Core Laboratories (NYSE:CLB)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
4/19/20173/31/2017$0.39$0.42$150.44 million$157.81 millionViewN/AView Earnings Details
1/25/201712/31/2016$0.41$0.41$145.78 million$149.54 millionViewN/AView Earnings Details
10/19/2016Q316$0.38$0.38$155.72 million$143.50 millionViewN/AView Earnings Details
7/20/2016Q216$0.35$0.35$146.37 million$148.10 millionViewN/AView Earnings Details
4/20/2016Q116$0.37$0.37$161.24 million$153.65 millionViewN/AView Earnings Details
1/27/2016Q415$0.65$0.65$179.48 million$182.70 millionViewListenView Earnings Details
10/21/2015Q315$0.83$0.83$203.29 million$197.27 millionViewListenView Earnings Details
7/22/2015Q215$0.77$0.82$195.13 million$204.00 millionViewListenView Earnings Details
4/22/2015Q115$0.85$0.86$211.82 million$213.64 millionViewN/AView Earnings Details
1/28/2015Q414$1.54$1.54$280.18 million$278.60 millionViewN/AView Earnings Details
10/22/2014Q314$1.52$1.53$284.30 million$276.14 millionViewListenView Earnings Details
7/23/2014Q214$1.35$1.35$269.70 million$267.56 millionViewListenView Earnings Details
4/23/2014Q114$1.45$1.45$283.02 million$262.90 millionViewListenView Earnings Details
1/30/2014Q413$1.40$1.43$278.55 million$276.30 millionViewListenView Earnings Details
10/17/2013Q313$1.34$1.36$267.21 million$273.16 millionViewN/AView Earnings Details
7/17/2013Q2 2013$1.31$1.32$267.24 million$263.14 millionViewListenView Earnings Details
4/17/2013Q1 2013$1.15$1.22$260.90 million$260.90 millionViewListenView Earnings Details
1/30/2013Q4 2012$1.13$1.17$246.49 million$254.46 millionViewListenView Earnings Details
10/17/2012$1.10$1.13ViewN/AView Earnings Details
7/18/2012$1.16$1.16ViewN/AView Earnings Details
4/18/2012$1.07$1.06ViewN/AView Earnings Details
2/1/2012$1.08$1.09ViewN/AView Earnings Details
10/19/2011$0.99$0.93ViewN/AView Earnings Details
4/19/2011$0.75$0.77ViewN/AView Earnings Details
2/9/2011$0.81$0.84ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Core Laboratories (NYSE:CLB)
2017 EPS Consensus Estimate: $2.62
2018 EPS Consensus Estimate: $3.44
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20173$0.39$0.81$0.53
Q2 20173$0.47$0.88$0.61
Q3 20173$0.55$0.97$0.72
Q4 20173$0.54$1.03$0.76
Q1 20181$0.73$0.73$0.73
Q2 20181$0.84$0.84$0.84
Q3 20181$1.00$1.00$1.00
Q4 20182$0.65$1.08$0.87
(Data provided by Zacks Investment Research)


Current Dividend Information for Core Laboratories (NYSE:CLB)
Most Recent Dividend:5/23/2017
Annual Dividend:$2.20
Dividend Yield:2.14%
Dividend Growth:19.80% (3 Year Average)
Payout Ratio:150.68% (Trailing 12 Months of Earnings)
99.55% (Based on This Year's Estimates)
68.32% (Based on Next Year's Estimates)
Dividend Payments by Quarter for Core Laboratories (NYSE:CLB)

Dividend History by Quarter for Core Laboratories (NYSE:CLB)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading and Institutional Ownership History for Core Laboratories (NYSE:CLB)
Insider Ownership Percentage: 1.00%
Insider Trades by Quarter for Core Laboratories (NYSE:CLB)
Institutional Ownership by Quarter for Core Laboratories (NYSE:CLB)
Insider Trades by Quarter for Core Laboratories (NYSE:CLB)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
2/1/2017Michael StraughenDirectorBuy106$118.65$12,576.90View SEC Filing  
1/30/2017Martha Z CarnesDirectorBuy200$115.20$23,040.00View SEC Filing  
2/2/2016Jan Willem SodderlandDirectorBuy300$93.90$28,170.00View SEC Filing  
5/12/2015Michael C KearneyDirectorSell1,000$128.52$128,520.00View SEC Filing  
11/17/2014Mark F ElvigVPSell1,000$138.03$138,030.00View SEC Filing  
7/28/2014Richard L BergmarkCFOBuy7,000$147.31$1,031,170.00View SEC Filing  
3/7/2014Michael KearneyDirectorSell2,000$193.00$386,000.00View SEC Filing  
2/14/2014Mark ElvigVPSell1,500$186.64$279,960.00View SEC Filing  
10/21/2013Monty L DavisCOOSell5,704$197.33$1,125,570.32View SEC Filing  
8/7/2013Richard BergmarkCFOSell20,000$149.58$2,991,600.00View SEC Filing  
7/25/2013Charles Brigham MillerCAOSell11,648$147.81$1,721,690.88View SEC Filing  
7/25/2013Monty L DavisCOOSell5,948$149.12$886,965.76View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for Core Laboratories (NYSE:CLB)
Latest Headlines for Core Laboratories (NYSE:CLB)
DateHeadline logoCore Laboratories (CLB) Expected to Post Quarterly Sales of $169.02 Million - May 26 at 4:08 PM logoWhy Is Core Laboratories (CLB) Down 6.8% Since the Last Earnings Report? - Nasdaq - May 24 at 4:11 PM logoCore Laboratories (CLB) Expected to Post Earnings of $0.50 Per Share - May 24 at 1:02 PM logoWhat Would Get Oil Back to $100 a Barrel? - May 24 at 12:45 PM logoWhy Is Core Laboratories (CLB) Down 6.8% Since the Last Earnings Report? - May 22 at 12:35 PM logoCore Laboratories Stock Tumbles as Billionaire Shares Bear Case - Motley Fool - May 16 at 4:22 PM logoCore Laboratories Stock Tumbles as Billionaire Shares Bear Case - May 15 at 4:25 PM logoHere's What Would Need to Happen for Oil Prices to Get Back to $100 - May 15 at 1:29 PM logoEinhorn at Sohn Investment Conference: Short Core Laboratories - May 11 at 4:57 PM logoSOHN Spotlight: Short Core Labs, Greenlight's Einhorn Says - Barron's - May 10 at 8:19 AM logoETFs with exposure to Core Laboratories NV : May 9, 2017 - May 9 at 9:22 PM logoDavid Einhorn shorts oil and gas stock Core Laboratories - - CNBC - May 9 at 8:15 AM logoThese Are Hedge Funds’ Best Stock Picks From the Sohn Conference - May 8 at 9:15 PM logoEinhorn bearish on Core Labs at Sohn Conference - May 8 at 9:15 PM logoDavid Einhorn shorts oil and gas stock Core Laboratories - May 8 at 9:15 PM logo[$$] Hedge Funds Pitch ‘Teletubbies,’ Tesla at Sohn - May 8 at 9:15 PM logoHow Schlumberger Correlates with Crude Oil - May 8 at 4:14 PM logoDavid Einhorn recommends Core Laboratories; Shares surge - May 8 at 4:14 PM logoGreenlight's Einhorn calls Core Labs shares 'way overvalued' - May 8 at 4:14 PM logoCore Laboratories (CLB) Receives Average Rating of "Hold" from Analysts - May 5 at 4:38 PM logoCore Laboratories NV breached its 50 day moving average in a Bullish Manner : CLB-US : May 4, 2017 - May 4 at 4:26 PM logo$169.02 Million in Sales Expected for Core Laboratories (CLB) This Quarter - May 3 at 3:10 PM logo Analysts Anticipate Core Laboratories (CLB) Will Post Earnings of $0.51 Per Share - May 1 at 3:58 PM logoCore Laboratories (CLB) Earns Daily News Impact Score of 0.28 - April 29 at 12:02 AM logoETFs with exposure to Core Laboratories NV : April 27, 2017 - April 27 at 4:49 PM logoCore Laboratories N.V. (CLB) Ex-Dividend Date Scheduled for April 26, 2017 - Nasdaq - April 27 at 7:14 AM logoCLB Crosses Above Key Moving Average Level - April 26 at 4:31 PM logoCore Laboratories NV :CLB-US: Earnings Analysis: Q1, 2017 By the Numbers : April 26, 2017 - April 26 at 4:31 PM logoCore Laboratories NV : CLB-US: Dividend Analysis : April 28th, 2017 (record date) : By the numbers : April 26, 2017 - April 26 at 4:31 PM logoCore Laboratories (CLB) Getting Somewhat Positive Media Coverage, AlphaOne Reports - April 24 at 8:12 PM logoScotiabank Analysts Give Core Laboratories (CLB) a $136.00 Price Target - April 23 at 11:52 PM logoCore Laboratories (CLB) Stock Rating Upgraded by Loop Capital - April 22 at 12:05 AM logoCore Laboratories (CLB) Upgraded at Zacks Investment Research - April 21 at 8:04 PM logoSomewhat Positive News Coverage Likely to Affect Core Laboratories (CLB) Share Price - April 21 at 5:05 PM logoCore Laboratories (CLB) Upgraded by ABN Amro to "Hold" - April 21 at 11:27 AM logoEdited Transcript of CLB earnings conference call or presentation 20-Apr-17 12:30pm GMT - April 21 at 9:24 AM logoCore Laboratories' (CLB) CEO David Demshur on Q1 2017 Results - Earnings Call Transcript - April 20 at 9:29 PM logoCore Laboratories (CLB) Tops Earnings and Revenues in Q1 - April 20 at 4:28 PM logoCore Laboratories NV breached its 50 day moving average in a Bearish Manner : CLB-US : April 20, 2017 - April 20 at 4:28 PM logoCore Laboratories N.V. Results Continue to Rebound - April 20 at 4:28 PM logoCore Laboratories (CLB) Releases Quarterly Earnings Results, Beats Expectations By $0.03 EPS - April 20 at 11:49 AM logoCore Laboratories (CLB) Tops Q1 EPS by 3c; Issues Solid Outlook - April 19 at 9:21 PM logoCore Lab Reports First Quarter 2017 Results: - April 19 at 9:21 PM logoCore Laboratories (CLB) Plans Quarterly Dividend of $0.55 - April 19 at 6:23 PM logoCore Laboratories (CLB) Updates Q2 Earnings Guidance - April 19 at 5:44 PM logoCore Laboratories tops Street 1Q forecasts - April 19 at 5:14 PM logoCore Laboratories beats by $0.03, beats on revenue - April 19 at 4:50 PM logoEarnings Reaction History: Core Laboratories N V, 60.0% Follow-Through Indicator, 6.4% Sensitive - April 19 at 4:19 PM logoCore Lab Announces Q2 2017 Quarterly Dividend - April 19 at 12:52 PM logoCore Laboratories (CLB) Getting Somewhat Favorable Media Coverage, Report Finds - April 18 at 2:20 PM



Core Laboratories (CLB) Chart for Saturday, May, 27, 2017

This page was last updated on 5/27/2017 by Staff